Life
Analysis Reveals Minimal Financial Impact of Drug Company Kickback Penalties
An analysis indicates that drugmakers penalized for kickbacks paid only 2.2% of their U.S. revenue from the implicated drugs over the past 25 years.
Editorial Staff 13 days ago